Stocks/KROS

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

KROS

↓ PDF (Pro)
Keros Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$11.82
+0.42%today
MKT CAP
$234M
+3.9% · 1Y
Earnings History
+48166.7%
+32.5%
+80.5%
-90.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$11.82
Low
$16.00
Analyst Mean
$22.57
High
$30.00
7 analystsNone
Full Financials
Trailing P/E5.1x
Forward P/E-2.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-97.3%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership3.6%
Institutional Ownership104.8%
Short % of Float8.14%
Days to Cover2.8d
1 Week+1.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
BIENAIME JEAN-JACQUESDirectorBuy1,000$11.70$0.01M2026-04-15
SEEHRA JASBIRChief Executive OfficerConversion55,000$0.30$0.02M2026-04-02
BIENAIME JEAN-JACQUESDirectorBuy2,000$11.21$0.02M2026-03-09
NEWTON CHARLES W.DirectorStock13,215$0.00$0.00M2026-03-09
SEEHRA JASBIRChief Executive OfficerSale7,015$16.17$0.11M2026-02-19
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution11.58%$0.03B-15.70%2025-12-31
Vanguard Group Incinstitution7.71%$0.02B-43.90%2025-12-31
Arrowstreet Capital, Limited Partnershipinstitution6.74%$0.02B+415.75%2025-12-31
State Street Corporationinstitution5.44%$0.01B-17.42%2025-12-31
Madison Avenue Partners, LPinstitution4.16%$0.01B-69.58%2025-12-31
Orbimed Advisors LLC.institution4.06%$0.01B-21.06%2025-12-31
Qube Research & Technologies Ltdinstitution3.96%$0.01B+158.61%2025-12-31
Jacobs Levy Equity Management, Inc.institution3.88%$0.01B+26.58%2025-12-31
Shaw D.E. & Co., Inc.institution3.82%$0.01B-43.26%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund3.59%$0.01B+0.68%2026-03-31
Federated Hermes, Inc.institution3.31%$0.01B+27.34%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund3.01%$0.01B-45.18%2025-12-31
Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fundfund1.84%$0.00B+0.00%2026-01-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund1.45%$0.00B+1.12%2026-02-28
iShares Trust-iShares Russell 2000 Value ETFfund1.24%$0.00B-3.82%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.08%$0.00B-45.29%2025-12-31
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fundfund0.98%$0.00B+100.00%2026-01-31
Vanguard Explorer Fundfund0.86%$0.00B-62.30%2026-01-31
Bridge Builder Trust-Bridge Builder Small/Mid Cap Growth Fundfund0.75%$0.00B+100.00%2025-12-31
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fundfund0.73%$0.00B-2.88%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total47
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for KROS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.